[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354205-105":59,"doc-detail-354205-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","sex-determining-region-y-box-protein-2-sox2-expression-alteration-regulation-and-its-diagnostics-prognostics-and-therapeutics-in-lung-cancer","Sex determining region Y box protein 2 (SOX2) - expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer","","Lung cancer causes the highest cancer mortality burden in China and worldwide. This study evaluates sex determining region Y box protein 2 (SOX2) as a biomarker and tests cordycepin (CD), a natural compound, for inhibitory activity against SOX2-driven oncogenic phenotypes in lung cancer. Using TCGA and UALCAN datasets plus Chinese patient samples, SOX2 is highly expressed at mRNA and protein levels in LUSC, while LUAD shows reduced protein with unchanged mRNA. High SOX2 correlates with worse survival across OS, FPS, DSS, and DFS, independent of mutation status. SOX2 overexpression promotes proliferation, migration, and invasion, whereas cordycepin suppresses these SOX2-mediated effects, supporting SOX2 for diagnostics, prognostics, and therapeutics in LUAD and LUSC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sex-determining-region-y-box-protein-2-sox2-expression-alteration-regulation-and-its-diagnostics-prognostics-and-therapeutics-in-lung-cancer/354205/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sex-determining-region-y-box-protein-2-sox2-expression-alteration-regulation-and-its-diagnostics-prognostics-and-therapeutics-in-lung-cancer/354205.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main purpose of the study regarding SOX2 in lung cancer?","Question",{"text":113,"@type":114},"To assess whether SOX2 can function as a biomarker and to evaluate cordycepin’s inhibitory effects on SOX2-driven oncogenic phenotypes in lung cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does SOX2 expression differ between LUSC and LUAD?",{"text":118,"@type":114},"In LUSC, SOX2 is highly expressed at both mRNA and protein levels. In LUAD, SOX2 mRNA levels are unchanged, while SOX2 protein levels are decreased.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationship is reported between SOX2 levels and patient outcomes?",{"text":122,"@type":114},"High SOX2 expression is significantly associated with poorer survival, including OS, FPS, DSS, and DFS, regardless of mutation status.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354205,1790167090,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Jiang et al. Discover Oncology (2026) 17:759 [https://doi.org/10.1007/s12672-026-04928-y](https://doi.org/10.1007/s12672-026-04928-y)  \nDiscover Oncology  \nRESEARCH Open Access  \nSex determining region Y box protein 2 (SOX2)  expression, alteration, regulation and its diagnostics, prognostics and therapeuticsin lung cancer  \nXia Jiang1,2,4†, Meiling Zheng1,4†, Lianmei Zhang3,4†, Dongmei Xu4, Jingliang Cheng4, Haoyue Deng1,4, Chunli Wei4, Junping Xian4,5, Fangshuo Xu4,5, Mazaher Maghsoudloo4, Dabing Li4,5, Wenzhe Ma1* and Junjiang Fu 1,4*  \n†Xia Jiang, Meiling Zheng and Lianmei Zhang have contributed equally to this work.  \n*Correspondence: Wenzhe Ma[wzma@must.edu. mo](wzma@must.edu. mo)[ ](wzma@must.edu. mo)Junjiang Fu [fujunjiang@swmu.edu.cn](fujunjiang@swmu.edu.cn)  \nFull list of author information is available at the end of the article  \nAbstract  \nLung cancer is the leading cause of cancer death in China and worldwide. Sex determining region Y box protein 2 (SOX2) is involved in pluripotency regulation in embryonic stem cells, morphogenesis, and homeostasis of tracheobronchial epithelia, as well as cancer. Given its oncogenic potential, this study aimed to investigate the potential of SOX2 as a biomarker and evaluate the inhibitory effects of cordycepin (CD), a natural compound, on SOX2-driven oncogenic phenotypes in lung cancer. In this study, by analyzing TCGA and UALCAN datasets together with Chinese patient samples, we found that SOX2 was highly expressed at both the mRNA and protein levels in LUSC. In LUAD, SOX2 mRNA levels were unchanged, whereas SOX2 protein levels were decreased. High SOX2 expression was significantly associated with poorer patient survival (including OS, FPS, DSS, and DFS), regardless of whether it was mutated or not. SOX2 alterations were mainly amplifications in cancers, including that LUSC is the highest (40 . 04% in all cases), and in LUAD is only the 14th highest (2 . 58% in all cases) among all cancers, implying that LUSC SOX2 showed high gene amplification that could affect gene expression. Moreover, overexpression of SOX2 promoted lung cancer cell growth, migration, and invasion, while CD, a natural product originally from the traditional Chinese medicine Cordyceps sinensis (BerK.), suppressed SOX2-mediated progression, including the growth, migration, and invasion of lung cancer. Taken together, these results implied that SOX2 is a potential biomarker for diagnostics, prognostics, and therapeutics for lung cancer, including LUAD and LUSC.  \nKeywords SOX2, Biomarker, Survival, Lung cancer, Cordycepin (CD)  \n1 Introduction  \nLung cancer represents the most significant cause of cancer-related mortality on a global scale, with an estimated 2 million new cases diagnosed annually and 1.76 million deaths attributed to the disease each year. Lung cancer is known as the king of cancer and is  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4.0/.  \nJiang et al. Discover Oncology (2026) 17:759 P","cbCaiqHCrQKyYQqL","https://ap.wps.com/l/cbCaiqHCrQKyYQqL","pdf",3661921,18,"English","# Abstract\n## Keywords\n# 1 Introduction","[{\"question\":\"What is the main purpose of the study regarding SOX2 in lung cancer?\",\"answer\":\"To assess whether SOX2 can function as a biomarker and to evaluate cordycepin’s inhibitory effects on SOX2-driven oncogenic phenotypes in lung cancer.\"},{\"question\":\"How does SOX2 expression differ between LUSC and LUAD?\",\"answer\":\"In LUSC, SOX2 is highly expressed at both mRNA and protein levels. In LUAD, SOX2 mRNA levels are unchanged, while SOX2 protein levels are decreased.\"},{\"question\":\"What relationship is reported between SOX2 levels and patient outcomes?\",\"answer\":\"High SOX2 expression is significantly associated with poorer survival, including OS, FPS, DSS, and DFS, regardless of mutation status.\"}]","Sex determining region Y box protein 2 (SOX2) - expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer | PDF",1790109474,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec28af6ddf35d3c66b4b6044b3b454a6.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78ef2bc8894cf948f3099781d865d358.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/755ba4f43498f6ce97d4df75aefab130.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12710a3f43b5f9d225e9d7558fef2ac4.webp",980,1306]